Clinical validation of a novel point-of-care diagnostic aid for early detection and monitoring of Alzheimer's Disease The Clinical protocol of 2D-BioPAD, a Horizon Europe Framework Programme

<p>Abstract titled “Clinical validation of a novel point-of-care diagnostic aid for early detection and monitoring of Alzheimer’s Disease. The Clinical protocol of 2D-BioPAD, a Horizon Europe Framework Programme”. The asbtract was presented on the 14th Panhellenic Conference on Alzheimer's Disease and 6th Mediterranean Conference on Neurodegenerative Diseases (13 of February - 16 of February 2025).</p> <p>The 2D-BioPAD project is funded by the European Union under GA no. 101120706. Views and opinions expressed are however those of the authors only and do not necessarily reflect those of the European Union or CNECT. Neither the European Union nor the granting authority can be held responsible for them.</p>

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-02-13
DOI
https://doi.org/10.5281/zenodo.14975404
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical validation of a novel point-of-care diagnostic aid for early detection and monitoring of Alzheimer's Disease The Clinical protocol of 2D-BioPAD, a Horizon Europe Framework Programme

Zenodo (CERN European Organization for Nuclear Research)
Dementia and Cognitive Impairment Research
article

Clinical validation of a novel point-of-care diagnostic aid for early detection and monitoring of Alzheimer's Disease The Clinical protocol of 2D-BioPAD, a Horizon Europe Framework Programme

article en

Abstract

<p>Abstract titled “Clinical validation of a novel point-of-care diagnostic aid for early detection and monitoring of Alzheimer’s Disease. The Clinical protocol of 2D-BioPAD, a Horizon Europe Framework Programme”. The asbtract was presented on the 14th Panhellenic Conference on Alzheimer's Disease and 6th Mediterranean Conference on Neurodegenerative Diseases (13 of February - 16 of February 2025).</p> <p>The 2D-BioPAD project is funded by the European Union under GA no. 101120706. Views and opinions expressed are however those of the authors only and do not necessarily reflect those of the European Union or CNECT. Neither the European Union nor the granting authority can be held responsible for them.</p>

Zenodo (CERN European Organization for Nuclear Research)
Partnerships for the goals
Openalex Percentile: Top 50%
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.